When you outsource your drug development program to a Contract Research Organization, you want access to the most experienced team available to assure successful oversight of your project. When your program calls for the emerging market regions, select a group that specializes in the intricacies of such a program and has a demonstrated track record of success in these regions.

PhaseON Clinical provides a unique combination of extensive expertise from first-in-class teams committed to the success of your global program. Our colleagues are already working with the top pharmaceutical and biotechnology companies, and have excelled in sponsor audits. With the most experienced teams in India, Mexico and Turkey individually have an average experience of catering to international clientele for over 20+ years and have been involved in successful completion of over 250 studies. Together, we can help you to minimize your risks by diversifying your approach to the emerging markets.

Our comprehensive range of integrated services provides a turn-key solution for your drug development program:

Phase I-IV full service clinical development incl. of Monitoring services and Global Project Management
Generic drug development incl. of PK endpoint studies in patients
Quality Assurance support and independent audits
Regulatory Affairs and Independent Ethics Committee submissions
In-depth customized feasibility assessments
Investigator identification and unique site management solutions
Drug Storage & Distribution
Data Management, Biostatistics, Medical writing incl. of final CSR
Training and consultation
Regulatory consultation: India & sub-continent, Central & Eastern Europe, Mexico, Latin America